Samsung Active Asset Management Launches KoAct China Biohealthcare Active ETF, Benchmarking the Solactive China Biohealthcare Index
you are currently viewing:Samsung Active Asset Management Launches KoAct China Biohealthcare Active ETF, Benchmarking the Solactive China Biohealthcare IndexJanuary 27, 2026-Solactive is pleased to announce its collaboration with Samsung Active Asset Management on the launch of the KoAct China Biohealthcare Active ETF, which uses the Solactive China Biohealthcare Index as a benchmark. The product aims to provide investors with targeted exposure to biohealthcare companies with a strong China and Hong Kong focus, reflecting the growing momentum of healthcare innovation and commercialization across the region. The biohealthcare sector continues to undergo a rapid transformation as advances in biologics and novel therapies progress from research into broader clinical adoption. In China, the shift from generics toward innovative biologics is supported by structural tailwinds, including an aging population and rising prevalence of chronic diseases, reinforcing long-term demand for healthcare solutions. Regulatory reforms are also supporting innovation by improving review processes and accelerating development timelines, while the growing use of AI, real-world data, and digital tools is enhancing efficiency in drug discovery and development. view more Source: Solactive |
March 17, 2026-China is relatively inured to the Iran conflict, but less external demand could hit its exports and its international partnerships may be undermined
The disruption to global energy flows triggered by the United States and Israel's attacks against Iran are a severe test of energy security, export resilience and geopolitical strategy for China, the world’s largest oil importer.
March 12, 2026-China Asset Management (Hong Kong) Limited ("ChinaAMC (HK) ") is pleased to announce the official launch
of the ChinaAMC HK-US AI ETF (the "Fund"), which will start trading on the Hong Kong Stock Exchange on
March 18.
The Fund closely tracks the "Solactive G2 AI 50 Select Index", comprising up to 50 leading AI companies listed
in Hong Kong and the United States.